Q4 2024 |
160 |
$5.19B |
+$159M |
-$823M |
-$664M |
ARGX, IONS, NBIX, ISRG, ITCI
|
13F-HR |
2/14/2025, 04:06 PM |
Q3 2024 |
162 |
$6.17B |
+$236M |
-$505M |
-$269M |
ARGX, IONS, VRTX, ISRG, ALNY
|
13F-HR |
11/14/2024, 05:16 PM |
Q2 2024 |
166 |
$6.15B |
+$428M |
-$706M |
-$278M |
IONS, ARGX, VRTX, NBIX, ISRG
|
13F-HR |
8/14/2024, 02:04 PM |
Q1 2024 |
168 |
$6.56B |
+$354M |
-$587M |
-$233M |
IONS, ARGX, NBIX, VRTX, ISRG
|
13F-HR |
5/15/2024, 02:57 PM |
Q4 2023 |
161 |
$6.54B |
+$445M |
-$807M |
-$362M |
IONS, ARGX, NBIX, VRTX, ISRG
|
13F-HR |
2/14/2024, 12:10 PM |
Q3 2023 |
164 |
$6.2B |
+$212M |
-$379M |
-$167M |
ARGX, IONS, VRTX, NBIX, ISRG
|
13F-HR |
11/14/2023, 01:54 PM |
Q2 2023 |
168 |
$7.01B |
+$379M |
-$604M |
-$225M |
VRTX, IONS, ARGX, ISRG, NBIX
|
13F-HR |
8/14/2023, 01:53 PM |
Q1 2023 |
159 |
$6.89B |
+$210M |
-$364M |
-$153M |
VRTX, IONS, ARGX, NBIX, ISRG
|
13F-HR |
5/15/2023, 10:12 AM |
Q4 2022 |
168 |
$7.53B |
+$333M |
-$292M |
+$40.6M |
IONS, ARGX, NBIX, VRTX, MRNA
|
13F-HR |
2/14/2023, 11:44 AM |
Q3 2022 |
176 |
$6.97B |
+$136M |
-$295M |
-$159M |
IONS, VRTX, ARGX, NBIX, ALNY
|
13F-HR |
11/14/2022, 12:52 PM |
Q2 2022 |
172 |
$7.07B |
+$415M |
-$568M |
-$153M |
IONS, ARGX, VRTX, NBIX, MRNA
|
13F-HR |
8/11/2022, 10:51 AM |
Q1 2022 |
177 |
$8.61B |
+$494M |
-$698M |
-$204M |
VRTX, IONS, ARGX, NBIX, MRNA
|
13F-HR |
5/13/2022, 04:19 PM |
Q4 2021 |
191 |
$9.7B |
+$843M |
-$328M |
+$515M |
MRNA, VRTX, ARGX, IONS, NBIX
|
13F-HR |
2/10/2022, 09:50 AM |
Q3 2021 |
219 |
$9.85B |
+$689M |
-$821M |
-$133M |
MRNA, VRTX, IONS, ARGX, NBIX
|
13F-HR |
11/12/2021, 06:30 AM |
Q2 2021 |
213 |
$10.2B |
+$934M |
-$737M |
+$197M |
MRNA, IONS, VRTX, NBIX, ARGX
|
13F-HR |
8/12/2021, 12:51 PM |
Q1 2021 |
216 |
$9.45B |
+$1.07B |
-$463M |
+$607M |
IONS, MRNA, NBIX, VRTX, ARGX
|
13F-HR |
5/11/2021, 05:46 PM |
Q4 2020 |
222 |
$8.73B |
+$1.09B |
-$570M |
+$516M |
IONS, NBIX, MRNA, VRTX, ARGX
|
13F-HR |
2/16/2021, 07:59 AM |
Q3 2020 |
216 |
$7.23B |
+$483M |
-$263M |
+$220M |
IONS, NBIX, INCY, VRTX, ARGX
|
13F-HR |
11/16/2020, 03:23 PM |
Q2 2020 |
208 |
$7.07B |
+$580M |
-$467M |
+$113M |
IONS, NBIX, INCY, VRTX, ESPR
|
13F-HR |
8/13/2020, 04:04 PM |
Q1 2020 |
214 |
$5.16B |
+$382M |
-$356M |
+$25.7M |
IONS, VRTX, NBIX, INCY, ALNY
|
13F-HR |
5/14/2020, 02:32 PM |
Q4 2019 |
215 |
$6.31B |
+$583M |
-$378M |
+$204M |
IONS, NBIX, INCY, VRTX, ESPR
|
13F-HR |
2/14/2020, 01:38 PM |
Q3 2019 |
210 |
$5.38B |
+$344M |
-$213M |
+$132M |
IONS, NBIX, INCY, VRTX, SAGE
|
13F-HR |
11/14/2019, 03:57 PM |
Q2 2019 |
201 |
$5.85B |
+$4.19B |
-$73.5M |
+$4.11B |
IONS, INCY, NBIX, VRTX, SAGE
|
13F-HR |
8/14/2019, 02:28 PM |
Q1 2019 |
136 |
$1.82B |
+$303M |
-$107M |
+$196M |
ALGN, ISRG, ABT, ILMN, TDOC
|
13F-HR |
5/15/2019, 03:12 PM |
Q4 2018 |
137 |
$1.45B |
+$298M |
-$93.6M |
+$204M |
ILMN, ABT, ISRG, ALGN, ELV
|
13F-HR |
2/12/2019, 04:17 PM |
Q3 2018 |
138 |
$1.58B |
+$287M |
-$42.4M |
+$244M |
ELV, ALGN, ABT, CELG, ILMN
|
13F-HR |
11/13/2018, 11:32 AM |
Q2 2018 |
138 |
$1.17B |
+$196M |
-$103M |
+$92.3M |
ELV, ALGN, CELG, ISRG, ILMN
|
13F-HR |
8/7/2018, 05:03 PM |
Q1 2018 |
124 |
$1.01B |
+$145M |
-$64.7M |
+$80.8M |
ALGN, ELV, CELG, ISRG, ABT
|
13F-HR |
5/9/2018, 02:42 PM |
Q4 2017 |
134 |
$957M |
+$147M |
-$107M |
+$40.1M |
CELG, ELV, ALGN, ISRG, ILMN
|
13F-HR |
2/14/2018, 02:48 PM |
Q3 2017 |
131 |
$956M |
+$159M |
-$65M |
+$94.3M |
CELG, AMGN, ALGN, GILD, ILMN
|
13F-HR |
11/13/2017, 11:20 AM |
Q2 2017 |
131 |
$844M |
+$126M |
-$56M |
+$70M |
CELG, AMGN, MDT, UNH, ELV
|
13F-HR |
8/14/2017, 01:23 PM |
Q1 2017 |
132 |
$750M |
+$243M |
-$26.7M |
+$216M |
CELG, AMGN, INCY, CNC, UNH
|
13F-HR |
5/11/2017, 02:37 PM |
Q4 2016 |
121 |
$487M |
+$45.6M |
-$55.4M |
-$9.82M |
CELG, SYK, MDT, UNH, ABT
|
13F-HR |
2/10/2017, 11:48 AM |
Q3 2016 |
121 |
$553M |
+$49.5M |
-$40.5M |
+$9.09M |
MDT, SYK, CELG, ILMN, BIIB
|
13F-HR |
11/10/2016, 03:19 PM |
Q2 2016 |
123 |
$531M |
+$85.6M |
-$69.4M |
+$16.3M |
MDT, SYK, CELG, ABT, CAH
|
13F-HR |
8/12/2016, 04:58 PM |
Q1 2016 |
130 |
$551M |
|
|
|
GILD, CELG, MDTXXXX, BIIB, ABT
|
13F-HR |
5/16/2016, 10:21 AM |